RenovoRx Inc Cash Flow-to-Debt Ratio
RenovoRx Inc cash flow-to-debt ratio. RenovoRx Inc (RNXT) has a Cash Flow-to-Debt Ratio of -1.15x as of June 2026, meaning its operating cash flow of $-2.87 Million could theoretically repay -1% of its total liabilities ($2.49 Million) in one year. See how financially flexible is RenovoRx Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of RenovoRx Inc (2019–2025)
Cash flow-to-debt ratio of RenovoRx Inc from 2019 to 2025. Historical debt coverage capacity for RenovoRx Inc across 7 annual periods. Also explore RenovoRx Inc (RNXT) equity growth momentum to track the company's year-over-year net asset growth rate.
RenovoRx Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
RenovoRx Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for RenovoRx Inc. For the full cash flow conversion analysis, see RNXT cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.11x | $-10.97 Million | $2.67 Million | ▼ -63.8% |
| 2024 | -2.51x | $-9.12 Million | $3.64 Million | ▼ -9.1% |
| 2023 | -2.30x | $-10.26 Million | $4.47 Million | ▲ +71.3% |
| 2022 | -8.00x | $-8.81 Million | $1.10 Million | ▼ -26.8% |
| 2021 | -6.31x | $-5.92 Million | $938.00K | ▼ -2862.2% |
| 2020 | -0.21x | $-3.53 Million | $16.57 Million | ▲ +94.9% |
| 2019 | -4.16x | $-3.35 Million | $805.00K | — |